Reckitt Benckiser, in the second week of December 2010, announced its plan to acquire Paras Pharmaceuticals for 3260 crore rupees. Actics which holds 63 percent stake in Paras Pharma will sell its entire holding in the company to Reckitt Benckiser.
Reckitt Benckiser is a household, health and personal care company, which has headquarters in UK (United Kingdom).
Paras Pharmaceuticals is Ahmadabad based. Other contenders for Paras included Emami, Mereck, Bayer, Johnson & Jhonson, Pfizer,Taisho and Sanofi.
Comments
All Comments (0)
Join the conversation